Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages

Area of Science:

• Immunology
• Microbiology
• Cell Biology

Background:

• Burkholderia pseudomallei causes melioidosis and survives within host cells.
• Macrophages are key in controlling intracellular bacterial infections.
• Interferons (IFNs) enhance macrophage antimicrobial functions.

Purpose of the Study:

• To investigate the mechanisms by which type I and type II IFNs regulate antimicrobial activity in B. pseudomallei-infected macrophages.
• To compare the efficacy of type I (IFN-beta) and type II (IFN-gamma) interferons in controlling intracellular B. pseudomallei growth.

Main Methods:

• Utilized a mouse macrophage cell line (RAW 264.7).
• Exposed cells to B. pseudomallei and either type I (IFN-beta) or type II (IFN-gamma) interferons.
• Assessed inducible nitric oxide synthase (iNOS) expression and intracellular bacterial killing.
• Measured interferon regulatory factor-1 (IRF-1) expression.

Main Results:

• Simultaneous exposure to B. pseudomallei and IFN-beta enhanced iNOS expression and bacterial killing.
• Preactivation with IFN-beta did not enhance iNOS expression or bacterial killing.
• IFN-gamma enhanced iNOS expression and bacterial killing regardless of timing (prestimulation or co-stimulation).
• IFN-gamma induced more sustained IRF-1 expression compared to IFN-beta.

Conclusions:

• The timing of interferon exposure is critical for type I IFN-mediated antimicrobial activity.
• Type II IFN (IFN-gamma) offers a more robust and timing-independent enhancement of macrophage antimicrobial activity against B. pseudomallei.
• Sustained IRF-1 expression by IFN-gamma likely contributes to its superior efficacy.